BDXBecton Dickinson
$179.86-2.64%Real quote · delayedMedical supplies🏛️ Company factsSEC filings + FINRA official data
Annual revenue $21.8B · latest quarter up 5.4% YoY · profitable (FY net income $1.7B) · short activity within its normal range.
FY revenue
$21.8B
2025-09
Latest Q YoY
+5.4%
Gross margin
12.9%
FY net income
$1.7B
Diluted EPS
$5.83
Short volume
52.9%
20d avg 55.9% · normal
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-08-07passive (13G)STATE STREET CORP
- 2026-08-06passive (13G)First Eagle Investment Management, LLC
- 2026-05-15passive (13G)T. Rowe Price Investment Management, Inc.
- 2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-04-29passive (13G)VANGUARD PORTFOLIO MANAGEMENT LLC
🎯 Market expectations
Expectation reliability High · 77/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$3.23 vs $3.14+2.87%
- Mar 2026$2.90 vs $2.77+4.69%
- Dec 2025$2.91 vs $2.82+3.19%
- Sep 2025$3.96 vs $3.92+1.02%
The takeaway
It has tracked consensus closely — no systematic over- or under-shooting.
Analyst estimates, not our forecast · not investment advice
What's moving this stock lately
No recent news affecting this stock
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
4 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →